Los Angeles Convention Center
Los Angeles, CA
May 16-20, 2023

Anemocyte Srl



Anemocyte welcomes you to ASGCT!

Anemocyte, a Biotech Manufacturing Organization based in Italy, offers development and manufacturing services and innovative solutions from R&D to GMP to address needs in the field of:

  • pDNA - Plasmids for Viral Vector and RNA manufacturing
  • mRNA – mRNA manufacturing for Vaccines and Therapies

Our experience:


> 20 years of manufacturing innovative Therapies and related starting materials
> 60 years of pharma solutions within our group of CDMOs (Nine Trees Group)


Come and meet our SMEs at booth 329!
For more information, please visit our website www.anemocyte.com   


 Products

  • Plasmids DNA
    PLASMID DNA MANUFACTURING FOR:

    • VIRAL VECTOR PRODUCTION
    • RNA SYNTHESIS
    • NON-VIRAL CELL MODIFICATION

    https://anemocyte.com/plasmid-manufacturing/...

  • Anemocyte Plasmids Unit:

    • With more than 500 sqm (about 5,000 square feet), the Plasmid Unit of Anemocyte addresses the manufacturing needs of Plasmid DNA for viral vector and RNA production from R&D to GMP.
    • All manufacturing steps are available in classified clean rooms.
    • Multiple segregated areas allow the performance of parallel manufacturing processes.
    • Flexible sizing of upstream fermentation 5-200L (higher volumes are possible) performed using animal-free media.
    • State-of-the-art equipment allowing the highest downstream flexibility

    MANUFACTURING Highlights

    Starting from 1 mg batch size.

    QUALITY Highlights

    Production and analysis are performed in ISO-certified laboratories.

    Most relevant features of cGMP manufacturing are applied (e.g., traceability, document control and materials segregation).

    All the equipment for production and analyses are validated (IQ/OQ protocols).

    All the starting materials and single-use components are certified as TSE-BSE free.

    The majority of analytical assays are performed in-house.